TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
For HCC patients with PVTT and APS, TACE combine with <sup>125</sup>I seed implantation in PVTT is a potentially effective and safe method that contributes to prolonging patient survival.
Authors
- Wei-Li Xia
- Yuan Guo (ORCID: https://orcid.org/0000-0003-4607-7356)
- Hong-Tao Hu (ORCID: https://orcid.org/0000-0002-5432-4014)
- Hai-Liang Li (ORCID: https://orcid.org/0000-0002-4497-5649)
- Xiao-Hui Zhao (ORCID: https://orcid.org/0000-0002-2482-5360)
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/jhc.s480082
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74